Lipid-lowering therapy in calcific aortic stenosis

被引:0
|
作者
Chan, KL [1 ]
Teo, K
机构
[1] Univ Ottawa, Inst Heart, Ottawa, ON K1Y 4W7, Canada
[2] McMaster Univ, Hamilton, ON L8N 3Z6, Canada
来源
NEW ENGLAND JOURNAL OF MEDICINE | 2005年 / 353卷 / 10期
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:1066 / 1066
页数:1
相关论文
共 50 条
  • [41] Effect of lipid-lowering therapy with bezafibrate on atherosclerotic aortic plaques in patients with hypertriglyceridemia
    Momiyama, Y
    Ayaori, M
    Fayad, ZA
    Yonemura, A
    Ohmori, R
    Kihara, T
    Sawada, S
    Tanaka, N
    Nakaya, K
    Ogura, M
    Taniguchi, H
    Kusuhara, M
    Nagata, M
    Nakamura, H
    Ohsuzu, F
    CIRCULATION, 2005, 112 (17) : U706 - U706
  • [42] Lipid Metabolism and Emerging Targets for Lipid-Lowering Therapy
    Gaudet, Daniel
    Drouin-Chartier, Jean-Philippe
    Couture, Patrick
    CANADIAN JOURNAL OF CARDIOLOGY, 2017, 33 (07) : 872 - 882
  • [43] Novel Lipid Markers of Calcific Aortic Valve Stenosis
    Bogaert, Pascal E.
    Edel, Andrea L.
    Surendran, Arun
    Raabe, Michael
    Sandhawalia, Shubhkarman
    Jassal, Davinder
    Ravandi, Amir
    CIRCULATION, 2018, 138
  • [44] Lowering inflammation through lipid-lowering therapy: are we there yet?
    Agarwal, Nayan
    Golwala, Harsh
    EUROPEAN HEART JOURNAL-QUALITY OF CARE AND CLINICAL OUTCOMES, 2020, 6 (02) : 93 - 94
  • [45] Effectiveness of hospital lipid-lowering protocol of intensive lipid-lowering therapy for patients with acute coronary syndrome
    Nakao, Sho
    Ishihara, Takayuki
    Tsujimura, Takuya
    Iida, Osamu
    Hata, Yosuke
    Toyoshima, Taku
    Higashino, Naoko
    Mano, Toshiaki
    JOURNAL OF CARDIOLOGY, 2022, 79 (03) : 391 - 399
  • [46] Should smoking be an indication for lipid-lowering therapy?
    Peeters, A
    Demos, LL
    McNeil, JJ
    MEDICAL JOURNAL OF AUSTRALIA, 1999, 170 (05) : 240 - 240
  • [47] Adherence with concomitant antihypertensive and lipid-lowering therapy
    Chapman, RH
    Benner, JS
    Petrilla, AA
    Tierce, JC
    Battleman, DS
    Schwartz, S
    CIRCULATION, 2003, 108 (17) : 756 - 757
  • [48] Perspectives on lipid-lowering therapy: Past and present
    Gotto, AM
    MULTIPLE RISK FACTORS IN CARDIOVASCULAR DISEASE: STRATEGIES OF PREVENTION OF CORONARY HEART DISEASE, CARDIAC FAILURE, AND STROKE, 1998, 12 : 25 - 33
  • [49] FREQUENCY AND LIPID-LOWERING THERAPY OF EXTREME HYPERTRIGLYCERIDEMIA
    Gurtsiev, Timur
    Chubykina, Uliana
    Tyurina, Alexandra
    Sokolov, Alexei
    Ezhov, Marat
    ATHEROSCLEROSIS, 2024, 399
  • [50] Lipid-lowering therapy in chronic kidney disease
    Fernández-Vega, F
    NEFROLOGIA, 2004, 24 (06): : 113 - 126